Status:
UNKNOWN
Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French Guiana
Lead Sponsor:
Centre Hospitalier de Cayenne
Collaborating Sponsors:
Hospital Avicenne
University Hospital, Montpellier
Conditions:
Hepatitis B, Chronic
Adults
Eligibility:
All Genders
18+ years
Brief Summary
In South America, the prevalence of HBV is variable but high (\> 8%) in the Amazon basin. In some areas, a third of HBsAg carriers are also infected with HDV, a major comorbidity factor. The pre-core ...
Detailed Description
Human demography and migrations play a crucial role in the phylogeography of viral populations. Hepatitis B viruses are characterized by a high genetic diversity which results from the fact that this ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Person with confirmed chronic hepatitis B
- Person who does not object to their participation in the protocol
- HBV viral load\> = 500 copies / mL
- Person who has planned / is willing to have their next HBV assessment of current care taken at the Cayenne Hospital center
Exclusion
- Refusal to participate
- Age \<18 years old
- Person opposing their participation in the protocol
- HBV viral load \<500 copies / mL
- Person who has not planned / been unwilling to have their next HBV assessment of current care taken at the Cayenne Hospital center
Key Trial Info
Start Date :
February 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04886102
Start Date
February 11 2021
End Date
February 1 2022
Last Update
May 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Cayenne
Cayenne, French Guiana, 97306